Bosello et al. study noted a higher incidence of impaired systolic function, ECG abnormalities, and worse outcomes in SSc patients with elevated cardiac enzymes (hs-cTnT and NT-proBNP) [74]. The gene discussed is NPPB; the disease is systemic sclerosis.